Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - desogestrel; ethinylestradiol - oral tablet - 150microgram ; 30microgram

Keňa - angličtina - Pharmacy and Poisons Board

n. v. organon b.v. kloosterstraat 6, 5349 ab, oss p. o. box 5340 bh - desogestrel and ethinylestradiol - tablet - 0.15 mg desogestrel and 0.03 mg ethinylestradiol… - hormonal contraceptives: fixed combinations of

Malta - angličtina - Medicines Authority

merck sharp & dohme limited hertford road, hoddesdon, hertfordshire en11 9bu, united kingdom - desogestrel, ethinylestradiol - tablet - desogestrel 150 µg ethinylestradiol 30 µg - sex hormones and modulators of the genital system

Tanzanie - angličtina - Tanzania Medicinces & Medical Devices Authority

organon south africa (pty) ltd, south africa - ethinylestradiol , desogestrel - tablets - 0.15 mg + 0.03 mg

Jihoafrická republika - angličtina - South African Health Products Regulatory Authority (SAHPRA)

organon south africa (pty) ltd - tablet - see ingredients - each tablet contains desogestrel 0,15 mg ethinylestradiol 0,03 mg

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - desogestrel 0.15mg;  ; ethinylestradiol 0.03mg;   - tablet - active: desogestrel 0.15mg   ethinylestradiol 0.03mg   excipient: colloidal silicon dioxide dl-alpha tocopheryl acetate lactose monohydrate magnesium stearate potato starch povidone stearic acid

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - ethinylestradiol, quantity: 0.03 mg; drospirenone, quantity: 3 mg - tablet, film coated - excipient ingredients: titanium dioxide; purified talc; lactose monohydrate; magnesium stearate; hypromellose; microcrystalline cellulose - indications: petibelle is indicated for use as an oral contraceptive.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - ethinylestradiol, quantity: 0.03 mg; drospirenone, quantity: 3 mg - tablet, film coated - excipient ingredients: lactose monohydrate; purified talc; titanium dioxide; magnesium stearate; hypromellose; microcrystalline cellulose - indications: yasmin is indicated for use as an oral contraceptive.

Kanada - angličtina - Health Canada

organon canada inc. - desogestrel; ethinyl estradiol - tablet - 0.15mg; 0.03mg - desogestrel 0.15mg; ethinyl estradiol 0.03mg - contraceptives

Kanada - angličtina - Health Canada

organon canada inc. - ethinyl estradiol; desogestrel - tablet - 0.03mg; 0.15mg - ethinyl estradiol 0.03mg; desogestrel 0.15mg - contraceptives